MedPath

A study of the therapeutic efficacy of PICSI in patients with repeated miscarriages after embryo transfer and patients with teratozoospermia

Not Applicable
Conditions
Repeated miscarriage patients after embryo transfer, Teratozoospermic patients
Registration Number
JPRN-UMIN000047539
Lead Sponsor
Shibakoen Kamiyama Clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
132
Inclusion Criteria

Not provided

Exclusion Criteria

Male infertile patients eligible for TESE/TESA/PESA. Patients undergoing ICSI using frozen thawed sperm. Patients who used study reagents within 30 days prior to egg retrieval. Patients who cannot have given written consent to participate in this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Day3 grade 1 embryo rate
Secondary Outcome Measures
NameTimeMethod
Fertilization rate, Blastocysto development rate, Clinical pregnancy rate, Abortion rate, HBA score
© Copyright 2025. All Rights Reserved by MedPath